Order Article Reprints

Kalinovsky DV, Kholodenko IV, Kibardin AV, Doronin II, Svirshchevskaya EV, Ryazantsev DY, Konovalova MV, Rozov FN, Larin SS, Deyev SM, et al. Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells. International Journal of Molecular Sciences. 2023; 24(2):1239. https://doi.org/10.3390/ijms24021239

Kalinovsky, Daniel V., Irina V. Kholodenko, Alexey V. Kibardin, Igor I. Doronin, Elena V. Svirshchevskaya, Dmitriy Y. Ryazantsev, Maria V. Konovalova, Fedor N. Rozov, Sergey S. Larin, Sergey M. Deyev, and et al. 2023. "Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells" International Journal of Molecular Sciences 24, no. 2: 1239. https://doi.org/10.3390/ijms24021239

Kalinovsky, D. V., Kholodenko, I. V., Kibardin, A. V., Doronin, I. I., Svirshchevskaya, E. V., Ryazantsev, D. Y., Konovalova, M. V., Rozov, F. N., Larin, S. S., Deyev, S. M., & Kholodenko, R. V. (2023). Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells. International Journal of Molecular Sciences, 24(2), 1239. https://doi.org/10.3390/ijms24021239